Delivery Order SPE2DB25D3003-SPE2DB25FPWFN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,609.85 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This competitively awarded, firm fixed-price delivery order is set to be completed by August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used in the management of hyperkalemia, a condition relevant to...
- The Defense Logistics Agency awarded a $7,533.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Veltassa 8.4 GM Powder Packet in a quantity of 30 units, with a ceiling value of $2,716.20. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $14,202.32 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime...
- The Defense Logistics Agency awarded a $3,988.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This is a non-set-aside contract with performance at the contractor's corporate office location in Conshohocken, Pennsylvania, and an ultimate completion date of September 12, 2025. Veltassa is a potassium-binding pharmaceutical used in the management of hyperkalemia, a common concern in military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units) with a ceiling value of $1,358.10. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. Veltassa is a potassium-binding...
- The Defense Logistics Agency awarded a delivery order valued at $3,173.79 to AmerisourceBergen Drug Corp for Veltassa 8.4 GM powder packets (30-count). The contract, issued on July 10, 2025, with an ultimate completion date of July 11, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $2,052.60 delivery order to AmerisourceBergen Drug Corp for Veltassa 16.8 GM powder packets (30-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used in the treatment of hyperkalemia, a condition commonly requiring...
- The Defense Logistics Agency awarded a $3,083.67 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for Veltassa 8.4 gm powder packets (30-count). This competitively awarded, firm fixed-price order is classified as a child contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. Veltassa is a potassium-binding medication used to treat hyperkalemia, a condition characterized by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count) valued at $3,964.51. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPWFNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,425.71 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (quantity 30) on April 22, 2025, with completion scheduled for April 23, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Veltassa is a potassium-binding medication used in clinical settings to manage hyperkalemia, a condition relevant to military and veteran healthcare populations. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical supply agreement. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies critical medical commodities including specialty medications, generic and brand-name drugs, vaccines, and medical devices to support Defense Health Agency and military healthcare systems worldwide. The company's consistent receipt of non-set-aside, competitively awarded contracts across a broad pharmaceutical portfolio demonstrates its established capability to meet federal medical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 4/22/25 |